The convergence of artificial intelligence (AI) and biotechnology presents incredible opportunities to accelerate scientific discovery and improve global health—opportunities that the United States must seize. At the same time, the dual-use nature of AI-enabled biotechnology poses new security challenges for policymakers worldwide. The cost and technical expertise required to develop bioweapons have been sharply declining for nearly a century. Now, rapid advancements in AI capabilities present two emerging biosecurity threats in which AI could assist actors in developing bioweapons.
Opportunities to Strengthen U.S. Biosecurity from AI-Enabled Bioterrorism: What Policymakers Should Know (Georgia Adamson and Gregory C. Allen – Center for Strategic & International Studies)
Related articles
